Sodium MRI

DIAGNOSTIC_TEST5 trials

Sponsors

Assistance Publique Hopitaux De Marseille, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Glenn Bauman, University of Cambridge, Centre Hospitalier St Anne

Conditions

ADAmyotrophic Lateral SclerosisChronic Heart DiseaseChronic Lung DiseaseDyspnea; UremicEnd Stage Renal DiseaseFTDHealthy Controls

Phase 2

Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy

Active, not recruitingNCT04053842

Glenn BaumanProstate Adenocarcinoma, Prostate Cancer, Prostate Neoplasm

Start: 2021-02-04End: 2025-09-30Target: 45Updated: 2025-03-13

Unknown Phase

Noninvasive Assessment of Neuronal Damage by MRI Sodium ( 23Na ) in Amyotrophic Lateral Sclerosis

Assistance Publique Hopitaux De MarseilleAmyotrophic Lateral Sclerosis

Start: 2015-09-30End: 2018-09-30Target: 60Updated: 2016-08-22

Dyspnea Assessment in Hemodialysis Patients

CompletedNCT03773991

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sChronic Heart Disease, Chronic Lung Disease, Dyspnea; Uremic +3

Start: 2019-03-29End: 2020-02-25Updated: 2024-08-15

Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques

RecruitingNCT06016075

University of CambridgeKidney Cancer

Start: 2023-01-01End: 2026-01-01Target: 30Updated: 2024-12-05

Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET

Not yet recruitingNCT07100470

Centre Hospitalier St AnneAD, FTD, Healthy Controls

Start: 2025-10-01End: 2029-03-01Target: 55Updated: 2025-08-03

Related Papers

Multiarm, non-randomised, single-centre feasibility study—investigation of the differential biology between benign and malignant renal masses using advanced magnetic resonance imaging techniques (IBM-Renal): protocol

BMJ Open2024-10-014 citations